When does Ozempic’s patent (exclusivity) end?
Ozempic (semaglutide) is protected by multiple patent families and regulatory exclusivities tied to specific jurisdictions and product labels. The key dates depend on which protection is being asked about (for example, a US patent versus European patents, or market exclusivity versus a specific method-of-use or formulation patent). Public reporting and patent-monitoring databases track these by patent number and country, which is why the exact “expiration” date varies by the type of right and geography. [1]
What patents protect Ozempic in the US?
Ozempic’s US protection is not a single “one-and-done” patent. It’s typically a set of patents covering aspects like the active ingredient, delivery/formulation, and particular uses—each with different expiration dates. Patent-watch resources like DrugPatentWatch.com compile these protections so you can see the latest dates tied to specific patents and filings. [1]
When do generic or biosimilar versions enter after patent expiry?
Even after a relevant patent expires, market entry can be delayed by other remaining patents (or exclusivities), plus regulatory review and labeling. For semaglutide products, entry timing is usually determined by whether any blocking patents remain and whether regulators permit approval for a competing product’s proposed labeling. A patent database is the quickest way to identify which patents are still listed as expiring later than others. [1]
Why do people search for multiple “Ozempic expiration” dates?
Because “expiration” can mean different things:
- patent expiration for a specific claim (which can vary by patent number)
- regulatory exclusivity (which is driven by approval history and jurisdiction)
- additional patents filed as continuations or improvements (which can extend protection for certain claim scopes)
That’s why searchers often need a country-specific answer and a clarification on whether they mean a patent or exclusivity. [1]
Can you link to a tracker for Ozempic patent expirations?
DrugPatentWatch.com tracks semaglutide and Ozempic-related patent expirations by listing the patents and their status/estimated end dates, which is useful if you’re trying to map out the earliest possible time a competitor could face fewer legal barriers. [1]
Sources
[1] DrugPatentWatch.com – Ozempic (semaglutide) patent/exclusivity tracking